Suppr超能文献

标记有二苯醚的新型二硒化物双席夫碱:下咽和乳腺腺癌选择性治疗的有前景候选物。

Novel Diselenide Bis-Schiff bases tagged with diphenyl ethers: Promising candidates for selective treatment of hypopharyngeal and breast adenocarcinoma.

作者信息

Hammouda Mohamed M, Shaaban Saad, Ba-Ghazal Hussein, Dawood Amal F, Zeidan Mohamed A, Al Khatib Arwa Omar, Alatawi Fatema S, Alomari Khadra B, Sharaky Marwa, Alaasar Mohamed, Al-Karmalawy Ahmed A

机构信息

Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.; Department of Chemistry, Faculty of Science, Mansoura University, 35516 Mansoura, Egypt.

Department of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia..

出版信息

Bioorg Chem. 2025 Aug;163:108670. doi: 10.1016/j.bioorg.2025.108670. Epub 2025 Jun 16.

Abstract

Organoselenium (OSe) compounds have received much attention due to their potential to inhibit tumor growth while also protecting cells from oxidative damage, making them promising cancer prevention agents. However, diphenyl diselenide (PhSe) has many drawbacks, such as increased lipophilicity with low oral bioavailability, toxicity issues due to poor selectivity, and limited physicochemical criteria. In this study, we developed two novel sets of diphenyl ether 5a-g and diphenyl ether hybridized with diselenide 6a-g and evaluated their anticancer activity and underlying cytotoxic mechanisms. Utilizing the growth inhibition percentage (GI%) assay, the anticancer activity of the newly synthesized candidates was evaluated against fifteen cancer cell lines. Furthermore, their potential safety and selectivity were tested against human skin fibroblast (HSF) cells. The analysis of structure-activity relationships (SAR) revealed that the human hypopharyngeal cancer cell line (FaDu) and human breast cancer cell line (MDA-MB-468) were the most sensitive to their growth inhibition effect. IC values were measured against the most sensitive ones (FaDu, MDA-MB-468, HCT-116, HELA, and A549 cells), where compounds 5b, 5c, and 6a manifested the highest mean IC values of 5.71, 4.49, and 6.22 μg/mL, respectively. Furthermore, the superior anticancer candidates 5b, 5c, and 6a were tested for apoptotic activity against a panel of apoptotic and anti-apoptotic markers. Moreover, compounds 5b, 5c, and 6a were estimated against inflammatory markers such as COX ІІ, IL-6, and IL-1β. Besides, the lead compounds (5b, 5c, and 6a) were docked against Caspase-6 and BCL-2 target receptors to investigate their apoptotic potential. Overall, candidates 5b, 5c, and 6a showed an attractive cytotoxic potential as anticancer agents with high selectivity towards hypopharyngeal and breast cancers with apoptotic and anti-inflammatory effects. Indeed, they provided a promising rationale for optimization studies and further mechanistic investigations to estimate their therapeutic potential.

摘要

有机硒(OSe)化合物因其具有抑制肿瘤生长的潜力,同时还能保护细胞免受氧化损伤,而备受关注,使其成为有前景的癌症预防剂。然而,二苯基二硒醚(PhSe)有许多缺点,如亲脂性增加导致口服生物利用度低、选择性差导致毒性问题以及理化标准有限。在本研究中,我们开发了两组新型的二苯醚5a - g和与二硒醚杂交的二苯醚6a - g,并评估了它们的抗癌活性和潜在的细胞毒性机制。利用生长抑制率(GI%)测定法,评估了新合成候选物对15种癌细胞系的抗癌活性。此外,还测试了它们对人皮肤成纤维细胞(HSF)的潜在安全性和选择性。结构 - 活性关系(SAR)分析表明,人下咽癌细胞系(FaDu)和人乳腺癌细胞系(MDA - MB - 468)对其生长抑制作用最为敏感。针对最敏感的细胞系(FaDu、MDA - MB - 468、HCT - 116、HELA和A549细胞)测量了IC值,其中化合物5b、5c和6a的平均IC值最高,分别为5.71、4.49和6.22μg/mL。此外,对优异的抗癌候选物5b、5c和6a针对一系列凋亡和抗凋亡标志物进行了凋亡活性测试。此外,还评估了化合物5b、5c和6a对炎症标志物如COX ІІ、IL - 6和IL - 1β的作用。此外,将先导化合物(5b、5c和6a)与半胱天冬酶 - 6和BCL - 2靶受体进行对接,以研究它们的凋亡潜力。总体而言,候选物5b、5c和6a作为抗癌剂显示出有吸引力的细胞毒性潜力,对下咽癌和乳腺癌具有高选择性,并具有凋亡和抗炎作用。事实上,它们为优化研究和进一步的机制研究提供了有前景的理论依据,以评估它们的治疗潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验